New England Journal of Medicine · 1970 · 126 citations · 25 references
Life SciencesBiochemistryClinical PharmacologyEnzymologyLipid BiochemistryCholesterol MetabolismLipid MetabolismLipid Metabolism DisordersLipoprotein MetabolismLiver DiseaseLiver Function TestsCholesterol EsterificationHepatic Dysfunction AssessmentHepatic Enzyme AlterationsHigh-density Lipoprotein MetabolismLiver Enzyme Abnormalities
Recent evidence indicates that the serum enzyme lecithin-cholesterol acyltransferase (LCAT) can esterify circulating cholesterol. The ability of serum to esterify 14C-cholesterol-labeled lipoproteins was used to assay LCAT acivity in 21 patients with liver disease, most of whom had disproportionately low levels of serum cholesterol esters. Activity was low in 14 patients, five having values under 5 μg of cholesterol esterified per ml per hour (control activities 20.4 to 34.1 μg per ml per hour, with a mean of 27.6). The defect was not due to circulating heat-stable inhibitors or to abnormal substrate lipoproteins in the patients' serum, but generally paralleled the severity of hepatic dysfunction. A direct relation existed between the patients' LCAT activities and the proportion of their serum cholesterol present as esters (r = 0.647, p less than 0.001). Low LCAT activity can at least partly explain the abnormal ratio of esterified to unesterified cholesterol in liver disease. The abnormality is probably due to impaired hepatic enzyme synthesis.
25
Phosphorus Assay in Column Chromatography
Grant R. Bartlett · Journal of Biological Chemistry · 1959 · 12.9K citations · Full text
The plasma lecithin:cholesterol acyltransferase reaction
John A. Glomset · Journal of Lipid Research · 1968 · 2.4K citations · Full text